Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2021, Vol. 48 Issue (1): 85-90    DOI: 10.31083/j.ceog.2021.01.5524
Original Research Previous articles | Next articles
Retrospective analysis of pregnancy terminations and indications in a tertiary center
Sureyya Saridas Demir1, *(), Erkan Cağliyan1, Sabahattin Altunyurt1
1Department of Obstetrics and Gynecology, Division of Perinatology, Dokuz Eylul University School of Medicine, 35340 Izmir, Turkey
Download:  PDF(174KB)  ( 108 ) Full text   ( 25 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Purpose: The aim of this study was to evaluate the indications of pregnancies terminated which were for maternal and fetal causes in our clinic and to discuss legal and ethical issues differing by countries. Methods: This study was performed retrospectively by evaluating 318 pregnancies terminated due to maternal or fetal indications over 10 weeks Results: TOP was performed due to fetal congenital, chromosomal and obstetrical reasons in 96.8% of 318 terminated cases and due to maternal reasons in 3.2% of them. Thirty-two (10%) late termination cases with gestational week > 23 + 0 were termed after feticide procedure. Conclusion: Gestational limit for termination of pregnancy varies from country to country, which brings ethical problems with it. We presented indications of pregnancy terminations in our clinic, which is a tertiary and reference center within the legal framework.
Key words:  Chromosomal and fetal abnormalities      Prenatal diagnosis      Termination of pregnancy     
Submitted:  14 February 2020      Revised:  22 August 2020      Accepted:  24 August 2020      Published:  15 February 2021     
*Corresponding Author(s):  Sureyya Saridas Demir     E-mail:  drsureyyademir@hotmail.com

Cite this article: 

Sureyya Saridas Demir, Erkan Cağliyan, Sabahattin Altunyurt. Retrospective analysis of pregnancy terminations and indications in a tertiary center. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(1): 85-90.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2021.01.5524     OR     https://ceog.imrpress.com/EN/Y2021/V48/I1/85

[1] J.R. Huang, X. Li, C. Fu, Y.H. Deng, T. Gao, H.W. Zhang. Is preprocessing helpful for suction and curettage in treating cesarean scar pregnancy?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 900-905.
[2] Y.J. Wu, C.J. Yu, W.H. Tian, Z. Xu. Prenatal diagnosis and molecular cytogenetic characterization of two hereditary chromosomal duplications with favorable outcomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(5): 789-791.
[3] B.F. Zhou, C.X. Duan, D.L. Tang. Methylmalonic acidemia in prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 617-619.
[4] D. Lu, D. Cao, Q. Zhao, X. Chen. Prenatal diagnosis and genetic counseling of mosaicism for chromosome t (7; 14) with a favorable outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 427-428.
[5] W. B. Wang, Q. Wu, Y. Zhou, X. Zhong, Y. Ge, J. Zhang. A 10-year retrospective study on prenatal cytogenetic analyses[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 248-252.
[6] Q.C. Wu, W.B. Wang, L. Sun, Y.S. Xu, X.J. Xie, X.M. Ma, Z.Y. Su. Mutation analysis of the fibroblast growth factor receptor 3 gene in fetuses with thanatophoric dysplasia, type I[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 7-11.
[7] G. Szabó, J. Rigó Jr.. Prenatal ultrasound diagnosis of abdominal pregnancy of ovarian origin[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 977-979.
[8] W. Homola, M. Zimmer. Safety of amniocentesis in normal pregnancies and pregnancies considered high-risk due to fetal genetic anomalies - an observational study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 403-407.
[9] D.Y. Ma, G. Liu, C.Y. Luo, A. Liu, J.J. Zhang, P. Hu, J. Cheng, Y.G. Wang, T. Jiang, J.F. Xu. A novel mutation in the mutations in the methyl-CpG-binding protein 2 (MECP2) gene in a Chinese patient with typical Rett syndrome and subsequent prenatal diagnosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 924-929.
[10] S. G. Erzincan, N. C. Sayin, C. Inan, M. A. Yuce, F. G. Varol, S. Basaran. Cell-free DNA testing: is it reliable? A case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 939-941.
[11] Bo Wang, Dan Lu, Zuliang Shi, Jian Ke, Qi Zhao, Hongjun Li. Prenatal diagnosis of a complex chromosomal rearrangement involving five chromosomes[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 797-799.
[12] Sun Young Jung, Yong Teak Oh, Suk Young Kim. Predict pregnancy outcomes of prenatal megaureter by prenatal ultrasonography[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 544-548.
[13] G. Capobianco, G. Virdis, C. Cherchi, A. Gulotta, P.L. Cherchi, S. Dessole. Diagnosis and management of fetal omphalocele: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 129-131.
[14] J. Han, X. Liu, Y. Zhao, Y. Zhang, L. Sun, X. Gu, X. Yang, Y. Li, Y. He. Prenatal diagnosis of absent pulmonary valve syndrome: results of a single-center experience in Beijing[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 834-838.
[15] L.J. Kong, L. Fan, G.H. Li, W.Y. Zhang. Prevalence of congenital malformations during pregnancy in China: screening by ultrasound examination[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 772-776.
No Suggested Reading articles found!